...
机译:伊马替尼在爆炸危机发生后的第二个慢性期接受异基因造血干细胞移植
Department of Hematology First Affiliated Hospital of Soochow University Jiangsu Institute of Hematology 188 Shizi Sreet 215006 Suzhou China;
Department of Hematology First Affiliated Hospital of Soochow University Jiangsu Institute of Hematology 188 Shizi Sreet 215006 Suzhou China;
Department of Hematology First Affiliated Hospital of Soochow University Jiangsu Institute of Hematology 188 Shizi Sreet 215006 Suzhou China;
Department of Hematology First Affiliated Hospital of Soochow University Jiangsu Institute of Hematology 188 Shizi Sreet 215006 Suzhou China;
Department of Hematology First Affiliated Hospital of Soochow University Jiangsu Institute of Hematology 188 Shizi Sreet 215006 Suzhou China;
Department of Hematology First Affiliated Hospital of Soochow University Jiangsu Institute of Hematology 188 Shizi Sreet 215006 Suzhou China;
Department of Hematology First Affiliated Hospital of Soochow University Jiangsu Institute of Hematology 188 Shizi Sreet 215006 Suzhou China;
Department of Hematology First Affiliated Hospital of Soochow University Jiangsu Institute of Hematology 188 Shizi Sreet 215006 Suzhou China;
Hematopoietic stem cell transplantation; Chronic myeloid leukemia; Imatinib; Blast crisis;
机译:异体干细胞移植前伊马替尼补充的清髓性全身照射/环磷酰胺调理作为合并治疗慢性粒细胞白血病危象患者
机译:慢性粒细胞性白血病的淋巴母细胞危机发生于接受骨髓移植治疗慢性粒细胞性白血病的同种异体白血病危机发生超过11年后。
机译:非清髓性同种异体干细胞移植后对甲磺酸伊马替尼的持久分子反应,用于持续治疗慢性粒细胞白血病的髓母细胞危机血液学
机译:重复脉冲磁刺激和酪氨酸激酶抑制剂慢性髓性白血病细胞系TCC-S的组合效应
机译:异基因造血干细胞移植后慢性移植物抗宿主病患者的症状,细胞因子和生活质量。
机译:Ponatinib作为高发性危机-慢性粒细胞白血病患者的异基因干细胞移植和/或常规化学治疗的有效替代策略:病例报告
机译:甲磺酸伊马替尼(IM)早期的慢性粒细胞白血病(CML)晚期异基因造血干细胞移植(HSCT)的结果